Repeatability and response to therapy of dynamic contrast-enhanced Magnetic Resonance Imaging biomarkers in rheumatoid arthritis in a large multicentre trial setting.
<h4>Objectives</h4> <p>To determine the repeatability, and response to therapy, of Dynamic Contrast-Enhanced (DCE) MRI biomarkers of synovitis in hand and wrist of Rheumatoid Arthritis (RA) patients, and in particular the performance of the transfer constant Ktrans, in a multicent...
Main Authors: | Taylor, P, Waterton, J, Ho, M, Nordenmark, L, Jenkins, M, DiCarlo, J, Guillard, G, Roberts, C, Buonaccorsi, G, Parker, G, Bowes, M, Peterfy, C, Kellner, H |
---|---|
Format: | Journal article |
Published: |
Springer
2017
|
Similar Items
-
A Case of Multicentric Reticulohistiocytosis Misdiagnosed as Rheumatoid Arthritis
by: Su Hee Song, et al.
Published: (2012-12-01) -
Use of magnetic resonance imaging to support dose selection in a phase II trial of baricitinib combined with conventional synthetic disease-modifying antirheumatic drugs in rheumatoid arthritis
by: Peterfy, C, et al.
Published: (2019) -
To Contrast or Not to Contrast? On the Role of Contrast Enhancement in Hand MRI Studies of Patients with Rheumatoid Arthritis
by: Miriam Frenken, et al.
Published: (2022-02-01) -
Magnetic Resonance Imaging Substudy in a Phase 2b Dose-Ranging Study of Baricitinib, an Oral Janus Kinase 1/Janus Kinase 2 Inhibitor, in Combination with Traditional Disease-Modifying Antirheumatic Drugs in Patients with Rheumatoid Arthritis.
by: Peterfy, C, et al.
Published: (2012) -
A role for angiogenesis in rheumatoid arthritis
by: D.G. Stupack, et al.
Published: (1999-05-01)